Arena Pharmaceuticals, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €46.52K -83.1% -€534.67M +53.3% -1,149,244.4% -10K pp -€328.27M +8.2% -705,607.4% -6.0K pp
    €274.83K -100.0% -€348.70M -201.8% -126,875.9% -1.3K pp -€303.50M -161.4% -110,430.7% -1.1K pp
    €694.78M +4,387.7% €342.51M -1,452.3% 49.3% +2.1 pp €494.11M -536.1% 71.1% +8.0 pp
    €15.48M -15.8% -€25.33M -67.8% -163.6% +2.6 pp -€113.31M +97.7% -731.9% -4.2 pp
    €18.38M -82.8% -€78.75M +306.0% -428.4% -4.1 pp -€57.32M +8.7% -311.8% -2.6 pp
    €106.81M +223.5% -€19.40M -79.1% -18.2% +2.6 pp -€52.72M -29.8% -49.4% +1.8 pp
    €33.02M +3.7% -€93.03M +78.5% -281.7% -1.2 pp -€75.06M -5.8% -227.3% +0.23 pp
    €31.85M -54.6% -€52.13M +211.3% -163.7% -1.4 pp -€79.69M -212.8% -250.2% -3.5 pp
    €70.12M +195.0% -€16.74M -77.3% -23.9% +2.9 pp €70.62M -293.9% 100.7% +2.5 pp
    €23.77M +116.9% -€73.64M -21.7% -309.8% +5.5 pp -€36.42M -45.6% -153.2% +4.6 pp
    €10.96M -23.4% -€94.10M -12.3% -858.7% -1.1 pp -€66.89M +61.4% -610.4% -3.2 pp
    €14.31M +59.9% -€107.29M -18.7% -749.6% +7.3 pp -€41.44M -68.1% -289.6% +12 pp
    €8.95M +5.9% -€131.99M -35.5% -1,475.0% +9.5 pp -€129.74M +1.3% -1,449.8% +0.66 pp
    €8.45M -49.3% -€204.68M +65.9% -2,422.0% -17 pp -€128.07M +34.3% -1,515.4% -9.4 pp
    €16.66M -36.8% -€123.34M +66.0% -740.6% -4.6 pp -€95.40M +95.0% -572.8% -3.9 pp
    €26.34M +31.6% -€74.31M +27.0% -282.1% +0.10 pp -€48.92M +44.6% -185.8% -0.17 pp
    €20.02M +69.8% -€58.50M +17.1% -292.3% +1.3 pp -€33.84M +13.0% -169.1% +0.85 pp
    €11.79M +6.6% -€49.96M +23.2% -423.7% -0.57 pp -€29.94M +101.0% -253.9% -1.2 pp
    €11.06M -33.9% -€40.54M +43.3% -366.7% -2.0 pp -€14.90M -343.4% -134.7% -1.7 pp
    €16.73M +7.5% -€28.28M +377.0% -169.0% -1.3 pp €6.12M -62.6% 36.6% -0.69 pp
    €15.56M +135.1% -€5.93M +8.2% -38.1% +0.45 pp €16.37M -1,123.1% 105.2% +1.3 pp
    €6.62M +∞% -€5.48M -37.9% -82.8% -0.83 pp -€1.60M -72.1% -24.2% -0.24 pp
    €0.00 -€8.82M N/A -€5.74M N/A

    Notifications